InsidersTradesSigma
신테카바이오 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 신테카바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 신테카바이오 has recorded 4 reports. Market capitalisation: €39.3bn. The latest transaction was reported on 6 July 2026 (Other). Among the most active insiders: 정종선. All data is openly available.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Fundamental score
Ranked 21,157 of 26,212 companies
30.0
score / 100
Value8
Quality52
FCF yld-24%
Earn yld-38%
EV/EBITDA·
ROE-59%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 July 2026
About 신테카바이오
신테카바이오 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions in the biotechnology field.